Nasser Sadr is a seasoned leader with 20 years of experience in cell and gene therapy, specializing in advanced therapy medicinal products (ATMP) across both academia and industry. They held various prominent roles, including CMC Leader at Galapagos and Sr Director of Global Analytical Development at uniQure, where they led the development and strategic oversight of analytical platforms for AAV gene therapy. Nasser obtained a Doctor of Philosophy in Bioengineering from Politecnico di Milano, where they also earned a Master of Engineering. Their research and consulting work have focused on innovative approaches to biofabrication and tissue engineering, aimed at transforming patient lives.
This person is not in any teams
This person is not in any offices